Symmetry Partners, LLC Horizon Therapeutics Public LTD CO Transaction History

Symmetry Partners, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Apr 03, 2023	SELL	$107.32 - $113.5 $1.33 Million - $1.4 Million	-12,353 Reduced 81.57%	2,791 $305,000
Q4 2021 Jan 11, 2022	SELL	$98.56 - $119.91 $79,242 - $96,407	-804 Reduced 5.04%	15,144 $1.63 Million
Q4 2020 Feb 18, 2021	BUY	$67.0 - $84.39 $40,066 - $50,465	598 Added 3.9%	15,948 $1.17 Million
Q3 2020 Nov 03, 2020	BUY	$55.23 - $79.93 $165,524 - $239,550	2,997 Added 24.26%	15,350 $1.19 Million
Q2 2020 Jul 20, 2020	SELL	$30.2 - $56.98 $190,743 - $359,885	-6,316 Reduced 33.83%	12,353 $687,000

Q1 2020 May 15, 2020	SELL	$24.87 - $38.56 $45,959 - $71,258	-1,848 Reduced 9.01%	18,669 $553,000
Q3 2019 Nov 04, 2019	BUY	$23.0 - $27.97 $471,891 - $573,860	20,517 New	20,517 $559,000

2.07M

20K

Ticker HZNP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 230,384,000
Description
Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...

Get notified when there are updates to the investment portfolio of Symmetry Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Symmetry Partners, LLC with notifications on news.